HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners
The JV combines HOCHDORF’s world-class Swiss production technology and manufacturing expertise with Pharmalys’ powerful brand portfolio
Hochdorf, Switzerland – August 2, 2026 – HOCHDORF and Pharmalys are proud to announce the official launch of a new, jointly owned company, Hochdorf Laboratories SA. This strategic joint venture (JV), led by HOCHDORF, is a key milestone in HOCHDORF's transformation, supported by its owner, AS Equity Partners.
The JV combines HOCHDORF’s world-class Swiss production technology and manufacturing expertise with Pharmalys’ powerful brand portfolio and established global market access. By integrating defined activities—including infant nutrition brands, intellectual property, and technical know-how—into one legal entity, the partnership will drive increased efficiency, faster decision-making, and sustainable, profitable growth.
The move aligns with AS Equity Partners’ strategy to leverage HOCHDORF’s operations on scalable, value-adding activities and international growth, while optimizing industrial utilization.
“The formation of this joint venture represents a decisive step forward in our vision for HOCHDORF. AS Equity Partners remains committed to providing the strategic and financial backing necessary to ensure this venture delivers long-term value for all stakeholders,” said Andreas Schulte, Founder and Managing Partner at AS Equity Partners.
“By bridging HOCHDORF’s industrial excellence with Pharmalys’ commercial strength, we are creating a high-performance platform poised for international expansion,” said Amir Mechria, Chairman of the Board at Pharmalys Laboratories.
.
______________________________________________________________________________
About AS Equity Partners: AS Equity Partners is a Zürich and London based private equity firm focused on control investments in mid-market companies within the technology and industrial sectors. The firm specializes in special situations, complex carve-outs and transformational growth, working closely with management teams to drive operational excellence and long-term value creation.
About HOCHDORF Swiss Nutrition: HOCHDORF is a leader in the Swiss market for the development, production, and marketing of high-quality products made from milk and other natural ingredients. and a specialist player in the global infant nutrition industry
About Pharmalys Laboratories: Pharmalys is a Swiss company specialized in premium infant nutrition. Known for its strong brands and extensive distribution network across 32 countries, Pharmalys specializes in delivering high-quality nutrition worldwide,
Media Contact:
Maitri O’Brien, Operating Partner
maitri.obrien@as-equitypartners.com
+41792382199
Press release distributed by Pressat on behalf of AS Equity Partners, on Monday 3 August, 2026. For more information subscribe and follow https://pressat.co.uk/
AS Equity Partners Hochdorf Swiss Nutrition Pharmalys Laboratories Infant Nutrition Swiss Production Food And Nutrition Business & Finance Food & Drink Health Manufacturing, Engineering & Energy Medical & Pharmaceutical
Media
No media attached. Please contact AS Equity Partners for more information.
You just read:
HOCHDORF Swiss Nutrition and Pharmalys Laboratories Announce Strategic Joint Venture to Accelerate Global Growth in Infant Nutrition, Backed by AS Equity Partners
News from this source:

